Clark Capital Management Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-38,316
| Closed | -$2.84M | – | 438 |
|
|
2024
Q4 | $2.84M | Sell |
38,316
-36
| -0.1% | -$2.67K | 0.02% | 241 |
|
|
2024
Q3 | $2.53M | Hold |
38,352
| – | – | 0.02% | 239 |
|
|
2024
Q2 | $3.54M | Sell |
38,352
-405
| -1% | -$37.4K | 0.03% | 199 |
|
|
2024
Q1 | $3.7M | Sell |
38,757
-5,887
| -13% | -$563K | 0.03% | 202 |
|
|
2023
Q4 | $3.4M | Sell |
44,644
-241
| -0.5% | -$18.4K | 0.03% | 200 |
|
|
2023
Q3 | $3.11M | Sell |
44,885
-52
| -0.1% | -$3.6K | 0.03% | 190 |
|
|
2023
Q2 | $4.24M | Sell |
44,937
-364
| -0.8% | -$34.3K | 0.04% | 175 |
|
|
2023
Q1 | $3.75M | Buy |
+45,301
| New | +$3.75M | 0.04% | 174 |
|
|
2022
Q4 | – | Sell |
-3,004
| Closed | -$248K | – | 358 |
|
|
2022
Q3 | $248K | Sell |
3,004
-124
| -4% | -$10.2K | ﹤0.01% | 322 |
|
|
2022
Q2 | $297K | Buy |
3,128
+44
| +1% | +$4.18K | ﹤0.01% | 294 |
|
|
2022
Q1 | $363K | Sell |
3,084
-440
| -12% | -$51.8K | ﹤0.01% | 322 |
|
|
2021
Q4 | $457K | Buy |
3,524
+1,393
| +65% | +$181K | 0.01% | 293 |
|
|
2021
Q3 | $241K | Buy |
+2,131
| New | +$241K | ﹤0.01% | 319 |
|
|
2021
Q2 | – | Sell |
-4,140
| Closed | -$346K | – | 341 |
|
|
2021
Q1 | $346K | Buy |
4,140
+117
| +3% | +$9.78K | 0.01% | 308 |
|
|
2020
Q4 | $367K | Hold |
4,023
| – | – | 0.01% | 310 |
|
|
2020
Q3 | $321K | Buy |
4,023
+129
| +3% | +$10.3K | 0.01% | 286 |
|
|
2020
Q2 | $269K | Sell |
3,894
-1,491
| -28% | -$103K | 0.01% | 280 |
|
|
2020
Q1 | $339K | Sell |
5,385
-51
| -0.9% | -$3.21K | 0.01% | 251 |
|
|
2019
Q4 | $423K | Buy |
5,436
+183
| +3% | +$14.2K | 0.01% | 264 |
|
|
2019
Q3 | $385K | Buy |
5,253
+393
| +8% | +$28.8K | 0.01% | 262 |
|
|
2019
Q2 | $299K | Buy |
+4,860
| New | +$299K | 0.01% | 265 |
|